NCT02197273View on ClinicalTrials.gov

Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA)

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Osteoarthritis, KneeOsteoarthritis, HipOsteoarthritis, Shoulder
Interventions
DRUG

Liposomal bupivacaine

DRUG

Standard of care analgesia

Trial Locations (1)

43214

OhioHealth Riverside Methodist Hospital, Columbus

Sponsors

Lead Sponsor

OhioHealth
All Listed Sponsors
lead

OhioHealth

OTHER

NCT02197273 - Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA) | Biotech Hunter | Biotech Hunter